Norgestimate
Showing 1 - 25 of 192
Contraception Trial in San Martino (Female Contraceptive)
Recruiting
- Contraception
- Female Contraceptive
-
San Martino, Genova, ItalyIRCCS Ospedale Policlinico
Sep 28, 2023
Contraception Behavior Trial in Aurora (Ethinyl Estradiol / Norgestimate Oral Tablet)
Recruiting
- Contraception Behavior
- Ethinyl Estradiol / Norgestimate Oral Tablet
-
Aurora, ColoradoChildren's Hospital Colorado
Aug 17, 2021
HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)
Contraception Trial (Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol)
Completed
- Contraception
- Norgestimate/ethinyl estradiol; Drospirenone/ethinyl estradiol
- (no location specified)
Mar 5, 2019
Healthy Trial in Dallas (lomitapide, EE/norgestimate)
Completed
- Healthy
-
Dallas, TexasCovance Clinical Research Unit, Inc
Nov 16, 2018
Primary Ovarian Insufficiency Trial in Philadelphia (Hormone Replacement Therapy, Combined Oral Contraceptives)
Withdrawn
- Primary Ovarian Insufficiency
- Hormone Replacement Therapy
- Combined Oral Contraceptives
-
Philadelphia, PennsylvaniaPenn Fertility Care
Jul 3, 2019
Healthy Trial in Overland Park (Rodatristat Ethyl, Moxifloxacin, Placebo for Rodatristat)
Recruiting
- Healthy
- Rodatristat Ethyl
- +3 more
-
Overland Park, KansasAltasciences Clinical Kansas, Inc.
Jul 5, 2023
Infections Joint Prosthetic Trial in France (amoxicillin or moxifloxacin, amoxicillin or moxifloxacin + rifampicin)
Not yet recruiting
- Infections Joint Prosthetic
- amoxicillin or moxifloxacin
- amoxicillin or moxifloxacin + rifampicin
-
Annecy, France
- +11 more
Jun 5, 2023
Triple Negative Breast Cancer Trial in Guangzhou (Gemcitabine and carboplatin plus antibiotic (moxifloxacin), Gemcitabine
Recruiting
- Triple Negative Breast Cancer
- Gemcitabine and carboplatin plus antibiotic (moxifloxacin)
- Gemcitabine combined with carboplatin plus placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 6, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Madison (EDP-305, Oral Contraceptive)
Completed
- NASH - Nonalcoholic Steatohepatitis
- EDP-305
- Oral Contraceptive
-
Madison, WisconsinCovance Clinical Research Unit
Jul 23, 2019
0.5% Moxifloxacin Hydrochloride Ophthalmic Solution in
Not yet recruiting
- Post Operative Endophthalmitis
- Moxifloxacin hydrochloride ophthalmic solution
- (no location specified)
Jan 11, 2023
Ocular Inflammation, Cataract Trial in Campinas (SATURNO II association, Vigadexa®)
Completed
- Ocular Inflammation
- Cataract
- SATURNO II association
- Vigadexa®
-
Campinas, São Paulo, BrazilAllegisa
Mar 4, 2022
Obesity Trial in Berlin (Cagrilintide, Cagrilintide Placebo, Moxifloxacin)
Not yet recruiting
- Obesity
- Cagrilintide
- +3 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Mar 27, 2023
Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to Trial in Karachi (Sequential Regimen:
Completed
- Helicobacter Pylori Infection
- Helicobacter Pylori Infection, Susceptibility to
- Sequential Regimen: Levofloxacin 500 mg BID, Amoxicillin 1 gm BID, omeprazole 20 mg BID for first five days followed by Levofloxacin 500 mgBID, Tinidazole 500 mg BID, Omeprazole 20 mg BID
- Triple Regimen: Moxifloxacin 400mg OD, Amoxicillin 1 gm BID, Omeprazole 20mgBID
-
Karachi, Sindh, PakistanJamal Noor Hospital, Karachi
May 8, 2023
Bioequivalence Trial in Karachi (Moksi® 400mg Tablet, Drug: Avelox® 400Mg Tablet)
Completed
- Bioequivalence
- Moksi® 400mg Tablet
- Drug: Avelox® 400Mg Tablet
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and Clinical Research (CBSCR)
Mar 31, 2022
HSV Infection Trial in London (Pritelivir and moxifloxacin , Pritelivir , moxifloxacin and moxifloxacin , Pritelivir ,
Recruiting
- HSV Infection
- Pritelivir and moxifloxacin placebo
- +2 more
-
London, United KingdomRichmond Pharmacology Ltd
Jan 3, 2023
Non-alcoholic Steatohepatitis Trial in Berlin (Cotadutide, Cotadutide-, Moxifloxacin)
Recruiting
- Non-alcoholic Steatohepatitis
- Cotadutide
- +3 more
-
Berlin, GermanyResearch Site
Jan 16, 2023